Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrique Alvarez

Showing results (61-70 of 247) with videos related to

Pageof 25
Sort By:
Multiple Sclerosis and Related Disorders|December 4, 2018
Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legalLaura Weinkle, Christopher H Domen, Ian Shelton, et al.
The Journal of Organic Chemistry|October 1, 2016
Oxidative Coupling of (-)-Sclareol and Related Diols Leading to Oxepane TerpenoidsHanane Bouanou, Juan A Gil, Ramón Alvarez-Manzaneda, et al.
Frontiers in Physiology|April 4, 2022
Multi-Scale Computational Modeling of Spatial Calcium Handling From Nanodomain to Whole-Heart: Overview and PerspectivesMichael A Colman, Enrique Alvarez-Lacalle, Blas Echebarria, et al.
Plos Computational Biology|December 9, 2020
Empirical model for short-time prediction of COVID-19 spreadingMartí Català, Sergio Alonso, Enrique Alvarez-Lacalle, et al.
Virology|May 3, 2008
Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic miceMarta L Dediego, Lecia Pewe, Enrique Alvarez, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 5, 2007
Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptomsManuel Gurpegui, Enrique Alvarez, Manuel Bousoño, et al.
Annals of Clinical and Translational Neurology|August 9, 2020
Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatmentBrandi L Vollmer, Kavita Nair, Stefan Sillau, et al.
Chemotherapy|August 24, 2007
Establishment of a single-dose irinotecan model of gastrointestinal mucositisRachel J Gibson, Joanne M Bowen, Enrique Alvarez, et al.
Multiple Sclerosis and Related Disorders|November 13, 2019
Sensory nerve stimulation causes an immediate improvement in motor function of persons with multiple sclerosis: A pilot studyAwad M Almuklass, Robyn A Capobianco, Daniel F Feeney, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 26, 2017
Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experienceBrandi Vollmer, Kavita V Nair, Stefan H Sillau, et al.
Pageof 25

Showing results (61-70 of 247) with videos related to

Sort By:
Pageof 25
Multiple Sclerosis and Related Disorders|December 4, 2018
Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legalLaura Weinkle, Christopher H Domen, Ian Shelton, et al.
The Journal of Organic Chemistry|October 1, 2016
Oxidative Coupling of (-)-Sclareol and Related Diols Leading to Oxepane TerpenoidsHanane Bouanou, Juan A Gil, Ramón Alvarez-Manzaneda, et al.
Frontiers in Physiology|April 4, 2022
Multi-Scale Computational Modeling of Spatial Calcium Handling From Nanodomain to Whole-Heart: Overview and PerspectivesMichael A Colman, Enrique Alvarez-Lacalle, Blas Echebarria, et al.
Plos Computational Biology|December 9, 2020
Empirical model for short-time prediction of COVID-19 spreadingMartí Català, Sergio Alonso, Enrique Alvarez-Lacalle, et al.
Virology|May 3, 2008
Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic miceMarta L Dediego, Lecia Pewe, Enrique Alvarez, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 5, 2007
Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptomsManuel Gurpegui, Enrique Alvarez, Manuel Bousoño, et al.
Annals of Clinical and Translational Neurology|August 9, 2020
Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatmentBrandi L Vollmer, Kavita Nair, Stefan Sillau, et al.
Chemotherapy|August 24, 2007
Establishment of a single-dose irinotecan model of gastrointestinal mucositisRachel J Gibson, Joanne M Bowen, Enrique Alvarez, et al.
Multiple Sclerosis and Related Disorders|November 13, 2019
Sensory nerve stimulation causes an immediate improvement in motor function of persons with multiple sclerosis: A pilot studyAwad M Almuklass, Robyn A Capobianco, Daniel F Feeney, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 26, 2017
Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experienceBrandi Vollmer, Kavita V Nair, Stefan H Sillau, et al.
Pageof 25